Clinical Trial Update: Hydroxychloroquine for Prevention of Recurrent Miscarriage. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating hydroxychloroquine for prevention of recurrent miscarriage is in the works, with status currently unspecified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Miscarriage

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: University Hospital, Brest | Conditions: Recurrent Miscarriage, First Trimester Abortion | Phase 3 | Status: UNKNOWN